Communicating Drug Discovery Data Efficiently and Effectively
Poster Feb 01, 2007
Jonathan Davies and Andrew Lemon
Drug discovery generates vast amounts of multidisciplinary data which needs to be captured, consistently organized and shared effectively across an organization.
In this poster, we present IDBS’ ActivityBase™ — a single, integrated framework that brings together biological and chemical information. The software integrates with Oracle®, the industry standard relational database and familiar Microsoft® applications such as Word and Excel.
With all discovery data in one system, the communication of information between scientists is simplified — enabling better, faster decisions — and the need for IT support to integrate disparate systems is eliminated.
IDBS is also pioneering software to predict drug efficacy and safety based on pre-clinical data, complementing the scientific expertise of researchers. By predicting potential problems with compounds earlier in the discovery process, costs are cut and efficiency is boosted.
Performance of the D5000 and High Sensitivity D5000 ScreenTape Assays for the 4200 TapeStation SystemPoster
Here, we focus on quantification, sizing, and sensitivity of both D5000 ScreenTape assays.READ MORE
CiPA Phase 2 Study: validation of an automated microelectrode array (MEA) assay of hiPSC-derived cardiomyocyte electrophysiology for cardiac safety evaluationPoster
These results support the use of hSC-CM and MEA technology for preclinical assessment of proarrhythmic risk within the proposed CiPA paradigm, and, more generally, demonstrate that automation of the CM-MEA assay can achieve high reliability and throughput for cardiac risk assessment in vitro.READ MORE